Etrasimod for Children with Ulcerative Colitis

This trial provides access to an investigational medicine called etrasimod for people with ulcerative colitis who have not been helped by at least three other treatments, or who cannot take them. It's a compassionate use program, meaning it's for patients with no other options.

This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.

This trial tests whether an oral medicine called ozanimod can improve ulcerative colitis (UC) in children whose disease is moderate to severe. It’s meant for kids who didn’t fully respond—or couldn’t tolerate—standard UC treatments.

This study tests a new combination treatment for moderate-to-severe ulcerative colitis (UC). The goal is to see if adding an investigational drug to an existing UC therapy helps reduce symptoms and improve the lining of the colon.

This trial tests new medicines for people with moderate to severe ulcerative colitis who haven't found relief with standard treatments. Participants will receive one of several investigational drugs (these are not yet approved and are being studied for safety and tolerability). The goal is to see if the drugs are safe and if they might help control symptoms.

This trial tests if etrasimod can prevent pouchitis, which is inflammation of the surgically created internal pouch, in people who have had their colon removed due to ulcerative colitis. If you are at high risk for pouchitis or have had only one episode, this study may help keep your pouch healthy.